Skip to main content
. 2019 May 20;30(6):e83. doi: 10.3802/jgo.2019.30.e83

Fig. 2. The ROC curves of CA 125, HE4, and ROMA. (A) In premenopausal women and (B) in postmenopausal women.

Fig. 2

CA 125, cancer antigen 125; HE4, human epididymis protein 4; ROC, receiver operating characteristic; ROMA, Risk of Ovarian Malignancy Algorithm.